Table 1 Baseline characteristics of patients

Age, years, median (range)

48 (34–67)

 < 50

13 (52.0%)

 ≥ 50

12 (48.0%)

Gender

 Male

24 (96.0%)

 Female

1 (4.0%)

Etiology

 HBV

23 (92.0%)

 HCV

1 (4.0%)

 Others

1 (4.0%)

ECOG performance score

 0

19 (76.%)

 1

6 (24.0%)

Child–Pugh Score

 5

20 (80.0%)

 6

2 (8.0%)

 7

2 (8.0%)

 8

1 (4.0%)

ALBI grade

 Grade 1

17 (68.0%)

 Grade 2

7 (28.0%)

 Grade 3

1 (4.0%)

AFP

 < 200

9 (36.0%)

 ≥ 200

16 (64.0%)

Tumor size, cm

 < 10

10 (40.0%)

 ≥ 10

15 (60.0%)

Tumor number

 < 4

5 (20.0%)

 ≥ 4

20 (80.0%)

PVTT

 Vp2

1 (4.0%)

 Vp3

8 (32.0%)

 Vp4

9 (36.0%)

 Absent

7 (28.0%)

IVCTT

 Hepatic vein invasion

3 (12.0%)

 IVC invasion

1 (4.0%)

 Absent

21 (84.0%)

Extrahepatic metastasis

 Present

3 (12.0%)

 Absent

22 (88.0%)